510(k) K955450

PATHROMTIN SL by Behring Diagnostics, Inc. — Product Code GFO

K955450 is an FDA 510(k) premarket notification submitted by Behring Diagnostics, Inc. for the device "PATHROMTIN SL". The FDA issued a decision of Substantially Equivalent on April 19, 1996. The device falls under product code GFO (Activated Partial Thromboplastin), a Class II device regulated under 21 CFR 864.7925. Behring Diagnostics, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 19, 1996
Date Received
November 29, 1995
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Activated Partial Thromboplastin
Device Class
Class II
Regulation Number
864.7925
Review Panel
HE
Submission Type